{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:44:36Z","timestamp":1761518676949},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":1088,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1999,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>To determine whether the administration of pharmacological quantities of iodine during interferon\u2010alpha (rIFN\u2010\u03b1) treatment of chronic viral hepatitis B and C (HCV) would exacerbate the potential adverse effects of rIFN\u03b1 on thyroid function.<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN<\/jats:title><jats:p>Thyroid function tests were carried out in 48 euthyroid patients before and during rIFN\u2010\u03b1 therapy of HCV. Twenty\u2010one of these patients were also treated with 10 drops saturated solution of potassium iodine (SSKI, \u223c350\u2003mg iodine daily). Eight patients with HCV but not treated with rIFN\u2010\u03b1 received 10 drops SSKI.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS<\/jats:title><jats:p>All patients were enthyroid prior to rIFN\u2010\u03b1 therapy for HCV or iodine and thyroid function tests were similar in the three groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENTS<\/jats:title><jats:p>Serum free T4, free T3, and TSH concentrations were measured prior to and at 30 and 60 days of rIFN\u2010\u03b1 therapy in the three groups of patients. The serum TSH response to TRH was assessed before rIFN\u2010\u03b1 therapy and on day 60. Thyroid peroxidase antibodies were measured before and during therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>During the 2\u2010month study period, similar small but significant decreases in serum FT4 and FT3 and compensatory small significant increases in TSH concentrations were observed in the patients treated with rIFN\u2010\u03b1\u2003+\u2003iodine and iodine alone but not in the patients receiving rIFN\u2010\u03b1 alone. Abnormal thyroid function tests were observed more frequently in patients receiving rIFN\u2010\u03b1\u2003+\u2003iodine and iodine alone compared to those receiving rIFN\u2010\u03b1 alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Excess iodine administered to patients treated with rIFN\u2010\u03b1 induced small changes in thyroid function similar to those observed in patients treated with iodine alone. Thus, rIFN\u2010\u03b1 and iodine do not appear to be synergistic in the development of abnormal thyroid function tests over a 2\u2010month treatment period.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1999.00616.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:39:48Z","timestamp":1047379188000},"page":"95-100","source":"Crossref","is-referenced-by-count":9,"title":["Recombinant interferon \u03b1 (rIFN\u2010\u03b1) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis"],"prefix":"10.1111","volume":"50","author":[{"given":"Roberta","family":"Minelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis E.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Valli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Schianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Pedrazzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Fiaccadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Magotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio","family":"Roti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-118-5-1977"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-127-4-1613"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.4048936"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344951"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.2.423"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.5.1424"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-4-859"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196910092811504"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-32-4-515"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.11.3140"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260127"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(88)90219-2"},{"key":"e_1_2_7_14_2","first-page":"491","article-title":"Thyrotropin receptor antibodies following treatment with recombinant a\u2010interferon in patients with hepatitis","volume":"125","author":"Fonseca V.","year":"1991","journal-title":"Acta Endocrinologica (Cophenh)"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.3.922"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.751768.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80291-6"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840100106"},{"key":"e_1_2_7_19_2","first-page":"370","article-title":"Lack of increased serum interleukin\u20106 and soluble IL\u20106 receptor concentrations in patients with thyroid diseases following recombinant human interferon a therapy","volume":"44","author":"Minelli R.","year":"1996","journal-title":"Journal of Investigative Medicine"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.2721081.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1996.0191"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","unstructured":"Roti E. Montermini M. Robuschi G. Gardini E. Salvo D. Gionet M. Abreau C.&Braverman L.E.(1987) Prevalence of hypothyroidism and Hashimoto's thyroiditis in two elderly population with different iodine intake. In:Thyroid Autoimmunity(eds A. Pinchera S.H. Ingbar J.M. McKenzie & G.F. Fenzi) pp.555\u2013557. Plenum Publishing Corporation New York.","DOI":"10.1007\/978-1-4613-0945-1_104"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-6-1581"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-5-958"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.5.1273"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.4.928"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00259-8"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.8.2976"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31958-7"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb01453.x"},{"key":"e_1_2_7_31_2","first-page":"788","article-title":"Autoimmune thyroid disease: further developments in our understanding","volume":"15","author":"Weetman A.P.","year":"1994","journal-title":"Endocrine Reviews"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1999.00616.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1999.00616.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1999.00616.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T14:52:46Z","timestamp":1698504766000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1999.00616.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1046\/j.1365-2265.1999.00616.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1999.00616.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}